ROKIT Healthcare, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ROKIT Healthcare, Inc. - overview
Established
2012
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Based in Seoul, South Korea, and founded in 2012 by CEO Seok-hwan You, ROKIT Healthcare, Inc. operates as a provider of INVIVO 4D, a medical solution for contamination-free organ regeneration. In March 2024, ROKIT Healthcare, Inc. received an undisclosed amount of pre-IPO funding from Widwin Investment.
The company provides a wide range of regenerative healthcare products, such as organ regeneration, bioprinting, anti-aging treatments, tissue banking, and veterinary regeneration. Additionally, the firm also provides solutions like SKIN, Cartilage, Kidney, Dr. INVIVO, and AI-based healthcare solutions.
Current Investors
DRADS Capital, KB Investment, DSC Investment
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development
Website
www.rokithealthcare.com/
Verticals
3D Printing, HealthTech
Company Stage
Series C
Total Amount Raised
Subscriber access only
ROKIT Healthcare, Inc. - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,297,894,155 | 10,192,489,926 | 3,989,921,794 | 6,740,674,713 | - | - | - |
| % Revenue Growth (YoY) | - | 343.6% | (60.9%) | 68.9% | - | - | - |
| EBITDA (USD) | (3,509,396,408) | (8,198,236,494) | (15,643,607,889) | (15,693,509,221) | - | - | - |
| Operating Income (USD) | (3,751,558,035) | (9,043,475,133) | (17,093,009,665) | (17,302,264,767) | - | - | - |
| Operating Margin | (163.3%) | (88.7%) | (428.4%) | (256.7%) | - | - | - |
| % EBITDA Margin | (152.7%) | (80.4%) | (392.1%) | (232.8%) | - | - | - |
| NET Income (USD) | (10,698,800,765) | (5,497,022,777) | (35,366,390,227) | (56,392,771,233) | - | - | - |
| % Net Margin | (465.6%) | (53.9%) | (886.4%) | (836.6%) | - | - | - |
ROKIT Healthcare, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | ROKIT Healthcare, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.